ArticleClinical and translational allergy2025

LP-003, a novel high-affinity anti-IgE antibody for inadequately controlled seasonal allergic rhinitis: A multicenter, randomized, double-blind, placebo-controlled phase 2 clinical trial.

Kai Guan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.